125 related articles for article (PubMed ID: 2421899)
1. Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: preparation and use in a radioimmunoassay for measuring NB/70K in serum.
Knauf S; Kalwas J; Helmkamp BF; Harwell LW; Beecham J; Lord EM
Cancer Immunol Immunother; 1986; 21(3):217-25. PubMed ID: 2421899
[TBL] [Abstract][Full Text] [Related]
2. Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and controls: a preliminary report of the use of the NB12123 and CA 125 radioimmunoassays alone and in combination.
Knauf S; Bast RC
Int J Biol Markers; 1988; 3(2):75-81. PubMed ID: 3243980
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of ovarian tumor antigen NB/70K: monoclonal antibody assays for distinguishing ovarian cancer from other gynecologic disease.
Knauf S
Am J Obstet Gynecol; 1988 May; 158(5):1067-72. PubMed ID: 3369485
[TBL] [Abstract][Full Text] [Related]
4. Selectivity for ovarian cancer of an improved serum radioimmunoassay for human ovarian tumor-associated antigen NB/70K.
Knauf S; Taillon-Miller P; Helmkamp BF; Bonfiglio TA; Beecham JB
Gynecol Oncol; 1984 Mar; 17(3):349-55. PubMed ID: 6706232
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody assays for measuring ovarian tumor antigen in blood. Detection of NB/70K in patients with ovarian cancer and nongynecologic diseases.
Knauf S
Cancer; 1988 Sep; 62(5):922-5. PubMed ID: 3409174
[TBL] [Abstract][Full Text] [Related]
6. Identification, purification, and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen.
Knauf S; Urbach GI
Cancer Res; 1981 Apr; 41(4):1351-7. PubMed ID: 6163521
[TBL] [Abstract][Full Text] [Related]
7. An improved radioimmunoassay for human ovarian tumor antigen NB/70K.
Knauf S; Taillon-Miller P
Gynecol Oncol; 1984 Sep; 19(1):67-73. PubMed ID: 6469090
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlations of ovarian cancer antigen NB/70K: a preliminary report.
Dembo AJ; Chang PL; Urbach GI
Obstet Gynecol; 1985 May; 65(5):710-4. PubMed ID: 3856794
[TBL] [Abstract][Full Text] [Related]
9. A study of the NB/7OK and CA 125 monoclonal antibody radioimmunoassays for measuring serum antigen levels in ovarian cancer patients.
Knauf S; Anderson DJ; Knapp RC; Bast RC
Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):911-3. PubMed ID: 2411137
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer.
Petru E; Sevin BU; Averette HE; Koechli OR; Perras JP; Hilsenbeck S
Gynecol Oncol; 1990 Aug; 38(2):181-6. PubMed ID: 2387533
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
[TBL] [Abstract][Full Text] [Related]
12. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
[TBL] [Abstract][Full Text] [Related]
13. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
[TBL] [Abstract][Full Text] [Related]
14. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.
Ohkawa K; Tsukada Y; Murae M; Kimura E; Takada K; Abe T; Terashima Y; Mitani K
Br J Cancer; 1989 Dec; 60(6):953-60. PubMed ID: 2605105
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
16. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
[TBL] [Abstract][Full Text] [Related]
17. A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II).
Nozawa S; Yajima M; Sasaki H; Tsukazaki K; Aoki D; Sakayori M; Udagawa Y; Kobayashi T; Sato I; Furusako S
Jpn J Cancer Res; 1991 Jul; 82(7):854-61. PubMed ID: 1715339
[TBL] [Abstract][Full Text] [Related]
18. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
[TBL] [Abstract][Full Text] [Related]
19. Detection of ovarian cancer by the humoral leukocyte adherence inhibition test using a purified tumor-associated antigen.
Kotlar HK; Knauf S; Beecham J; Kjørstad K; Sanner T
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):483-6. PubMed ID: 3891363
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.
Miotti S; Canevari S; Ménard S; Mezzanzanica D; Porro G; Pupa SM; Regazzoni M; Tagliabue E; Colnaghi MI
Int J Cancer; 1987 Mar; 39(3):297-303. PubMed ID: 2434438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]